BackF-star Therapeutics Overview

F-star Therapeutics Total Liabilities

F-star Therapeutics's total liabilities is $27M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$26.78M
8.33% YoYΔ $2.06M vs prior year quarter

Peer trimmed avg / median

Loading

F-star Therapeutics Total Liabilities History

Loading

F-star Therapeutics vs. peers: Total Liabilities Comparison

Loading

F-star Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

F-star Therapeutics (FSTX) FAQ

As of the most recent data (September 2022), FSTX shows a total liabilities of $27M. That compares with $25M in the prior-year period — up 8.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FSTX's total liabilities is now $27M (was $25M) — a 8.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether F-star Therapeutics is outperforming or lagging.

Tracking FSTX's total liabilities over time shows whether F-star Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $27M That compares with $25M in the prior-year period — up 8.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has F-star Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $27M) with ownership activity and broader fundamentals.

F-star Therapeutics's total liabilities is $27M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.